Pfizer, Merck, AstraZeneca and Bristol Myers Squibb were among the many biopharmas showing off novel cancer modalities at ...

Vivek Subbiah, MD, highlights key topics at the 50th European Society for Medical Oncology (ESMO) Congress, including the rise of tumor-agnostic therapies and the use of artificial intelligence (AI) ...

Sacituzumab govitecan significantly improved survival outcomes for previously untreated, PD-L1-negative metastatic ...

In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer ...

Final results from the pivotal CheckMate 238 trial showed adjuvant nivolumab continues to significantly improve RFS compared with ipilimumab for patients with advanced melanoma, according to data ...

In September 2024, Sanofi entered an exclusive licensing agreement with Orano Med and RadioMedix to globally commercialize ...

Sapanisertib combined with weekly paclitaxel improved PFS in platinum-resistant ovarian cancer, reducing the risk of death by 34% compared to paclitaxel alone. The combination therapy was generally ...

HousingAnywhere reports that emerging cities like Porto, Leipzig, and Valencia are ideal for career growth, affordability, ...

Previous presidents learned that large defeats in the midterms elections stops their legislative agenda cold. Could it happen ...

The return of the Israeli hostages from Hamas imprisonment is a day of international jubilation that will be long remembered.

Lymphoma survivors with chronic fatigue participating in a multidisciplinary intervention program experienced a beneficial effect on fatigue and on some aspects of health-related quality of life ...

EU diplomats meet in Brussels on the 19th package of Russia sanctions after Austria lifts its veto, foreign ministers in ...